Eli Lilly and Company

Activity in this selectionUnited States · Oct 14, 2026 · Jul 17, 2026

By stage

Series B3

Series A2

Series C+1

Biotech5

Healthtech1

United States6

6 in this selection

Oct 6

An online healthcare store where people compare care options and upfront prices, book visits and order medications or lab tests.

$120MSeries B

Participant

Aug 17

Develops neuro-metabolic therapeutics for schizophrenia and ALS

$30MSeries A

Role not disclosed

Aug 12

Clinical-stage biopharma developing injectable therapies for hair loss

$26MSeries B

Role not disclosed

Aug 12

Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease

$77MSeries B

Role not disclosed

Aug 10

Develops durable protein therapeutics via gene therapy for chronic diseases

$10MSeries A

Role not disclosed

Jul 31

Developing best-in-class radiopharmaceuticals for cancer treatment

$70MSeries C

Role not disclosed